11.0 Funding of HCV Testing

Posted in: HCV

11.1 Funding of HCV testing

Funding for HCV testing is provided both directly from the Commonwealth on a fee-for- service basis through the Medicare funding arrangements and also through specific State and Territory funding arrangements, which may include provision of free and de-identified HCV testing when used to inform treatment or clinically indicated.

11.2 Funding arrangements for HCV diagnostic and monitoring tests

More detailed information on Medicare benefits for hepatitis C tests is available here:  (See the most recent schedule Category 6– Pathology items and descriptions).51

A Medicare benefit for pathology testing for hepatitis C will be payable where the service was determined to be necessary by the patient's medical practitioner, was provided by an accredited pathology laboratory, and the patient meets the requirements for the relevant MBS item. Benefits would be payable for the attendance and tests which are considered reasonably necessary according to a patient’s individual circumstances.

11.3 Schedule Interpretation

The Department of Human Services is responsible for the day-to-day administration and payment of benefits under the Medicare arrangements. Any inquiries concerning matters of interpretation of Schedule items should be directed to the Department of Human Services in the first instance. For enquiries relating exclusively to the Schedule, phone 132 150.

Alternatively, send an email to This email address is being protected from spambots. You need JavaScript enabled to view it. .

Quick links to resources on this page

Medicare Benefits Schedule

51.Australian Government. Department of Health and Ageing. Medicare Benefits Schedule. Available at: (Cited 23 March 2012).